H Häfner1, K Maurer, W an der Heiden. 1. The Schizophrenia Research Group, Central Institute of Mental Health, Mannheim Faculty of Medicine/University of Heidelberg, J5, 68159, Mannheim, Germany. heinz.haefner@zi-mannheim.de
Abstract
PURPOSE: The ABC Schizophrenia study, led by a single research team, investigated a schizophrenia sample systematically over quarter of a century. This paper summarises results from 1996 onwards. The initial goals were to explain the considerably higher age at first admission in women, and to obtain precise information on the onset and early course of schizophrenia as a prerequisite for early intervention. METHOD: The study was hypothesis-driven. People with schizophrenia were compared in the prodrome and at first admission to those with unipolar depression and to healthy controls. We analysed the medium-term (5-year) and the long-term (12-year) course of schizophrenia, its symptom dimensions, social parameters and predictors. SAMPLES: (1) 276 population-based first admissions (232 first episodes) of schizophrenia (age range 12-59 years); (2) a subsample of 130 first admissions for schizophrenia; (3) 130 first admissions for unipolar depression; (4) 130 healthy population controls and (5) 1,109 consecutive first admissions for schizophrenia spectrum disorder without an age limit. RESULTS: The prodromal stages of schizophrenia and depression were very similar until positive symptoms appeared. The most frequent symptom in schizophrenia was depressed mood. The course of psychosis from prodrome to 12 years following first admission was very variable. From 5 to 12 years after first admission the course was characterised by irregular exacerbations of the main symptom dimensions, with no overall deterioration or improvement. CONCLUSIONS: Schizophrenic psychosis and severe affective disorder, rather than representing discrete illnesses, probably mark different stages in the manifestation of psychopathology produced by various degrees of brain dysfunction.
PURPOSE: The ABC Schizophrenia study, led by a single research team, investigated a schizophrenia sample systematically over quarter of a century. This paper summarises results from 1996 onwards. The initial goals were to explain the considerably higher age at first admission in women, and to obtain precise information on the onset and early course of schizophrenia as a prerequisite for early intervention. METHOD: The study was hypothesis-driven. People with schizophrenia were compared in the prodrome and at first admission to those with unipolar depression and to healthy controls. We analysed the medium-term (5-year) and the long-term (12-year) course of schizophrenia, its symptom dimensions, social parameters and predictors. SAMPLES: (1) 276 population-based first admissions (232 first episodes) of schizophrenia (age range 12-59 years); (2) a subsample of 130 first admissions for schizophrenia; (3) 130 first admissions for unipolar depression; (4) 130 healthy population controls and (5) 1,109 consecutive first admissions for schizophrenia spectrum disorder without an age limit. RESULTS: The prodromal stages of schizophrenia and depression were very similar until positive symptoms appeared. The most frequent symptom in schizophrenia was depressed mood. The course of psychosis from prodrome to 12 years following first admission was very variable. From 5 to 12 years after first admission the course was characterised by irregular exacerbations of the main symptom dimensions, with no overall deterioration or improvement. CONCLUSIONS:Schizophrenic psychosis and severe affective disorder, rather than representing discrete illnesses, probably mark different stages in the manifestation of psychopathology produced by various degrees of brain dysfunction.
Authors: H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler Journal: Soc Psychiatry Psychiatr Epidemiol Date: 1998-08 Impact factor: 4.328
Authors: Judith Rietdijk; Marjolein Fokkema; Daniel Stahl; Lucia Valmaggia; Helga K Ising; Sara Dragt; Rianne M C Klaassen; Dorien H Nieman; Rachel Loewy; Pim Cuijpers; Philippe Delespaul; Don H Linszen; Mark van der Gaag Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-10-15 Impact factor: 4.328
Authors: Berend Malchow; Katriona Keller; Alkomiet Hasan; Sebastian Dörfler; Thomas Schneider-Axmann; Ursula Hillmer-Vogel; William G Honer; Thomas G Schulze; Andree Niklas; Thomas Wobrock; Andrea Schmitt; Peter Falkai Journal: Schizophr Bull Date: 2015-03-17 Impact factor: 9.306
Authors: Rachel N Pläschke; Edna C Cieslik; Veronika I Müller; Felix Hoffstaedter; Anna Plachti; Deepthi P Varikuti; Mareike Goosses; Anne Latz; Svenja Caspers; Christiane Jockwitz; Susanne Moebus; Oliver Gruber; Claudia R Eickhoff; Kathrin Reetz; Julia Heller; Martin Südmeyer; Christian Mathys; Julian Caspers; Christian Grefkes; Tobias Kalenscher; Robert Langner; Simon B Eickhoff Journal: Hum Brain Mapp Date: 2017-09-06 Impact factor: 5.038
Authors: Kristin M Healey; David L Penn; Diana Perkins; Scott W Woods; Richard S E Keefe; Jean Addington Journal: Schizophr Bull Date: 2018-02-15 Impact factor: 9.306
Authors: Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt Journal: Schizophr Bull Date: 2019-06-18 Impact factor: 9.306
Authors: B Moreno-Küstner; F Mayoral; D Navas-Campaña; J M García-Herrera; P Angona; C Martín; F Rivas Journal: Epidemiol Psychiatr Sci Date: 2014-10-15 Impact factor: 6.892
Authors: Joshua Chiappelli; Peter Kochunov; Katherine DeRiso; Kavita Thangavelu; Hemalatha Sampath; Florian Muellerklein; Katie L Nugent; Teodor T Postolache; William T Carpenter; L Elliot Hong Journal: Schizophr Res Date: 2014-08-27 Impact factor: 4.939